申请人:Takeda Pharmaceutical Company Limited
公开号:EP2208726A1
公开(公告)日:2010-07-21
The present invention provides a cyclic amide derivative useful as a drug for treating thrombosis, which is represented by the formula (I):
wherein R1 represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X1 represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y1 represents - C(O)-, -S(O)- or -S(O)2-, A represents a piperazine ring which may be further substituted or a piperidine ring which may be further substituted, X2 represents a bond or an optionally substituted lower alkylene, Y2 represents -C(O)-, -S(O)-, -S(O)2- or -C(=NR7)-, X3 represents an optionally substituted C1-4 alkylene or an optionally substituted C2-4 alkenylene, Z3 represents -N(R4)-, -O- or a bond, Z1 represents -C(R2)(R2')-, -N(R2)-, etc., and Z2 represents - C(R3)(R3')-, -N(R3)-, etc., or a salt thereof.
本发明提供了一种可用作治疗血栓形成药物的环酰胺衍生物,它由式 (I) 表示:
其中 R1 代表任选取代的环烃基或任选取代的杂环基,W 代表键或任选取代的二价链烃基,a 代表 0、1 或 2,X1 代表任选取代的低级亚烷基或任选取代的低级亚烯基,Y1 代表 -C(O)-、-S(O)- 或 -S(O)2-、A 代表可被进一步取代的哌嗪环或可被进一步取代的哌啶环,X2 代表键或任选取代的低级亚烷基,Y2 代表 -C(O)-、-S(O)-、-S(O)2- 或 -C(=NR7)-,X3 代表任选取代的 C1-4 亚烷基或任选取代的 C2-4 烯基,Z3 代表 -N(R4)-、-O- 或键,Z1 代表 -C(R2)(R2')-、-N(R2)- 等。,Z2代表-C(R3)(R3')-、-N(R3)-等,或其盐。